Organogenesis Overview
- Founded
- 1985

- Status
- Public
- Employees
- 900

- Stock Symbol
- ORGO

- Investments
- 5
- Share Price
- $9.50
- (As of Friday Closing)
Organogenesis General Information
Description
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
Contact Information
- 85 Dan Road
- Canton, MA 02021
- United States
Organogenesis Timeline
Organogenesis Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$9.50 | $9.49 | $2.47 - $10.51 | $1.21B | 128M | 601K | -$0.05 |
Organogenesis Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 479,659 | 576,879 | 59,694 | 384,282 |
Revenue | 306,136 | 260,981 | 193,449 | 198,508 |
EBITDA | 11,495 | (21,877) | (46,980) | (912) |
Net Income | (4,943) | (40,454) | (64,831) | (8,388) |
Total Assets | 246,428 | 220,687 | 163,678 | 148,722 |
Total Debt | 114,731 | 100,606 | 59,261 | 102,335 |
Organogenesis Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Organogenesis‘s full profile, request access.
Request a free trialOrganogenesis Comparisons
Industry
0000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialOrganogenesis Competitors (23)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ViaCyte | Venture Capital-Backed | San Diego, CA | 00 | 00000 | 000000 - 000 | 00000 |
00000000 | Venture Capital-Backed | South San Francisco, CA | 00 | 00000 | 0000000000 | 00000 |
000000000 | Corporation | Melbourne, Australia | 000 | 00000 | 000000000 | 00000 |
00000000 | Venture Capital-Backed | Durham, NC | 000 | 00000 | 000000000 - | 00000 |
00000000 | Formerly VC-backed | San Diego, CA | 00 | 000.00 | 000000000 | 000.00 |
Organogenesis Executive Team (8)
Organogenesis Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
0000 0000 | Organogenesis | Chairman & Board Member | 000 0000 |
0000 0000000000 00. | Organogenesis | Chief Executive Officer & Board Member | 000 0000 |
000000 00000000 | Self | Board Member | 000 0000 |
00000 000000 | Organogenesis | Board Member | 000 0000 |
Organogenesis Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialOrganogenesis Acquisitions (5)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000 00000000000 | 17-Sep-2020 | 000000000000000000 | 0000 | Surgical Devices | 0000 0000000000 00. |
000000 0000000000 | 10-Dec-2018 | 000000000000000000 | Holding Companies | 0000 0000000000 00. | |
000000 0000000 | 28-Mar-2017 | 000000000000000000 | Surgical Devices | 0000 0000000000 00. | |
00000 (0000000000 | 17-Jan-2014 | 000000000000000000 | 00000 | Pharmaceuticals | |
NanoMatrix | 25-Feb-2008 | Merger/Acquisition | Biotechnology | 00000 000000 |
Organogenesis Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
NuTech Medical | Surgical Devices | Birmingham, AL | 1994 |
000 00000000000 | Surgical Devices | Largo, FL |